Infliximab for IPILIMUMAB-Related Colitis--Letter

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-15-2471
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Letter: Dose Optimising Infliximab in Acute Severe Ulcerative Colitis

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Letter: Should We Intensify Infliximab in Acute Severe Ulcerative Colitis?

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Pneumocystis Jirovecii Pneumonia in a Patient With Melanoma Treated With Infliximab and Corticosteroids for Ipilimumab-Associated Colitis

Global Dermatology
2016English

Nivolumab-Induced Colitis Treated by Infliximab

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2017English

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

New England Journal of Medicine
Medicine
2005English

Phase I Trial: SABR and Ipilimumab—Letter

Clinical Cancer Research
Cancer ResearchOncology
2017English

Reply to Letter to the Editor: Effect of Accelerated Infliximab Induction on Outcomes of Acute Severe Ulcerative Colitis

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2019English

Cost-Utility Analysis of Infliximab and Adalimumab for Refractory Ulcerative Colitis

Cost Effectiveness and Resource Allocation
Health Policy
2009English

A Type II Segmental Vitiligo Developed Under Infliximab Treatment for Ulcerative Colitis

Annals of Dermatology
Dermatology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy